Browse > Article
http://dx.doi.org/10.14406/acu.2014.002

Acupuncture for Prehypertension and Stage 1 Hypertension in Postmenopausal Women: Protocol for a Randomized Controlled Pilot Trial  

Kim, Jung-Eun (Acupuncture, Moxibustion & Meridian Research Group, Korea Institute of Oriental Medicine)
Choi, Jin-Bong (College of Korean Medicine, Dongshin University)
Kim, Hyeong-Jun (College of Korean Medicine, Semyung University)
Kang, Kyung-Won (Acupuncture, Moxibustion & Meridian Research Group, Korea Institute of Oriental Medicine)
Liu, Yan (Acupuncture, Moxibustion & Meridian Research Group, Korea Institute of Oriental Medicine)
Jung, Hee-Jung (Acupuncture, Moxibustion & Meridian Research Group, Korea Institute of Oriental Medicine)
Lee, Min-Hee (Acupuncture, Moxibustion & Meridian Research Group, Korea Institute of Oriental Medicine)
Shin, Mi-Suk (Acupuncture, Moxibustion & Meridian Research Group, Korea Institute of Oriental Medicine)
Kim, Jae-Hong (College of Korean Medicine, Dongshin University)
Choi, Sun-Mi (Acupuncture, Moxibustion & Meridian Research Group, Korea Institute of Oriental Medicine)
Publication Information
Korean Journal of Acupuncture / v.31, no.1, 2014 , pp. 5-13 More about this Journal
Abstract
Objectives : This study aims to evaluate the effectiveness and safety of acupuncture and explore the appropriate number of treatment for postmenopausal women diagnosed with prehypertension and stage 1 hypertension. Methods : A 4-arm randomized open label pilot trial will be performed at 2 centers. Sixty participants will be divided into 2 treatment groups and 2 control groups. Treatment groups will receive acupuncture at 8 points(bilateral GB20, LI11, ST36, SP6) for 4 weeks(treatment group A, 10 total sessions) or 8 weeks(treatment group B, 20 total sessions), while maintaining usual care. Control groups will not receive acupuncture but will be under usual care for 16 weeks(control group C) or 20 weeks(control group D). Each patient's living habits will be corrected and drugs that may affect blood pressure(BP) will be prohibited. Treatment group A and control group C will be evaluated at 4, 8, 12, and 16 weeks after randomization, while treatment group B and control group D will be evaluated at 4, 8, 12, 16, and 20 weeks after randomization. The major outcome variable is the magnitude of change in diastolic BP levels at 4 weeks after randomization; auxiliary outcome variables are (1) diastolic BP change at 8, 16, and 20 weeks, (2) systolic BP change, (3) BP control rate, (4) lipid profiles, and (5) high-sensitivity C-reactive protein. Patient safety will be assessed at every visit. Results and Conclusions : The study findings may help develop evidence for the effectiveness and safety of acupuncture for BP control.
Keywords
acupuncture; prehypertension; hypertension; randomized controlled trial;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Staessen J, Bulpitt CJ, Fagard R, Lijnen P, Amery A. The influence of menopause on blood pressure. J Hum Hypertens. 1989 ; 3(6) : 427-33.
2 Chun BY, Shin JY. The scientific evidence for the management of prehypertensives and high risk group. J Korean Med Assoc. 2011 ; 54(10) : 1013-9.   DOI   ScienceOn
3 Barton M, Meyer MR. Postmenopausal hypertension: mechanisms and therapy. Hypertension. 2009 ; 54(1) : 11-8.   DOI   ScienceOn
4 Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003 ; 42(6) : 1206-52.   DOI   ScienceOn
5 Kim YM, Hong KS, Choi YH, Choi MG, Jeong JY, Lee JM, et al. Rates and related factors of progression to hypertension among prehypertensive local residents ageed 45 or over in Chuncheon city: Hallym aging study from a community-based cross-sectional study. Korean Circ J. 2008 ; 38(1) : 43-50.   과학기술학회마을   DOI   ScienceOn
6 Liszka HA, Mainous AG 3rd, King DE, Everett CJ, Egan BM. Prehypertension and cardiovascular morbidity. Ann Fam Med. 2005 ; 3(4) : 294-9.   DOI   ScienceOn
7 Kim KI, Kim CH. Recent advance in the treatment of hypertension. J Korean Med Assoc. 2010 ; 53(3) : 208-13.   DOI
8 Elliott WJ. What factors contribute to the inadequate control of elevated blood pressure? J Clin Hypertens(Greenwich). 2008 ; 10(1 Suppl 1) : 20-6.   DOI
9 Pharmaceutical Safety Bureau. Guideline on clinical trial of medical products in the treatment of hypertension. Korea Food & Drug Administration website. 2009[cited 2013 December 6]. Available from: URL: http://drug.mfds.go.kr/Data/KO_DU/20100803175403_0.pdf
10 Rabito MJ, Kaye AD. Complementary and alternative medicine and cardiovascular disease: an evidence-based review. Evid Based Complement Alternat Med. 2013 ; 2013 : 672097.
11 Lee HS, Kim SY, Park JB, Kim YJ, Lee HJ, Park HJ. Acupuncture for lowering blood pressure: systemic review and metaanalysis. American J hypertens. 2009 ; 22(1) : 122-8.   DOI   ScienceOn
12 Jung SY, Park JE, Kim JE, Kim AR, Choi SM. Review of acupuncture treatment for hypertension in clinical trials. J Korean Orient Med. 2012 ; 33(1) : 12-23.   과학기술학회마을
13 European Medicines Agency. Principles for clinical evaluation of new antihypertensive drugs. EMEA website. 2006[cited 2013 December 6]. Available from: URL: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002927.pdf.
14 Korean Acupuncture and Moxibustion Society. Acupuncture and Moxibustion. 2nd ed. Paju : Jipmoondang. 2008 : 29, 63, 80, 234.
15 Kim HG, Jung KG, Kim SM, Min YK, Kim CH, Youn HM, et al. Literary review on the acupuncture and moxibustion therapy of hypertension. J Spine Joint Korean Med. 2006 ; 3(1) : 15-23.
16 World Health Organization. WHO standard acupuncture point locations in the Western Pacific Region. 1st ed. Seoul : Elsevier Korea. 2008 : 43, 67, 76, 185.
17 MacPherson H, Altman DG, Hammerschlag R, Youping L, Taixiang W, White A, et al. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture(STRICTA): Extending the CONSORT statement. J Evid Based Med. 2010 ; 3(3) : 140-55.   DOI   ScienceOn
18 Macpherson H. Pragmatic clinical trials. Complement Ther Med. 2004 ; 12 : 136-40.   DOI   ScienceOn
19 Korea Centers for Disease Control and Prevention(KCDC). Results of the Secondary Follow-up Survey of the Anseong and Ansan Cohorts. KCDC website. 2008[cited 2014 February 22]. Available from: URL: http://www.cdc.go.kr/CDC/contents/CdcKrContentView.jsp?cid=24667&viewType=CDC&menuIds=HOME001-MNU1136-MNU1223-MNU1353.)
20 Appel LJ, Champagne CM, Harsha DW, Cooper LS, Obarzanek E, Elmer PJ, et al. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA. 2003 ; 289(16) : 2083-93.
21 Seo SM, Baek SH, Jeon HK, Kang SM, Kim DS, Kim WS, et al. Correlations between the level of high-sensitivity C-reactive protein and cardiovascular risk factors in Korean adults with cardiovascular disease or diabetes mellitus: the CALLISTO study. J Atheroscler Thromb. 2013 ; 20(7) : 616-22.   DOI   ScienceOn
22 Ryu SY, Lee YS, Park J, Kang MG, Kim KS. Relations of plasma high-sensitivity C-reactive protein to various cardiovascular risk factors. J Korean Med Sci. 2005 ; 20(3) : 379-83.   과학기술학회마을   DOI   ScienceOn
23 Moon JS, Park KM, Choi SM. Study on the development of a questionnaire software for health examination in oriental medicine. J Korea Institute Orient Med. 2007 ; 13(2) : 135-42.   과학기술학회마을
24 ICH Expert Working Group. Statistical principles for clinical trials E9. ICH harmonized tripartite website. 2005[cited 2013 December 6]. Available from: URL: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E9/Step4/E9_Guideline.pdf.
25 Flachskampf FA, Gallasch J, Gefeller O, Gan J, Mao J, Pfahlberg AB, et al. Randomized trial of acupuncture to lower blood pressure. Circulation. 2007 ; 115(24) : 3121-9.   DOI   ScienceOn
26 Devilly GJ, Borkovec TD. Psychometric properties of the credibility/expectancy questionnaire. J Behav Ther Exp Psychiatry. 2000 ; 31(2) : 73-86.   DOI   ScienceOn
27 Yin C, Seo B, Park HJ, Cho M, Jung W, Choue R, et al. Acupuncture, a promising adjunctive therapy for essential hypertension: a double-blind, randomized, controlled trial. Neurol Res. 2007 ; 29(Suppl 1) : S98-103.   DOI   ScienceOn
28 Macklin EA, Wayne PM, Kalish LA, Valaskatgis P, Thompson J, Pian-Smith MC, et al. Stop Hypertension with the Acupuncture Research Program(SHARP): results of a randomized, controlled clinical trial. Hypertension. 2006 ; 48(5) : 838-45.   DOI   ScienceOn
29 Adrian W, Mike C, Jacqueline F. An introduction to western medical acupuncture. 1st ed. Seoul : Elsevier Korea. 2010 : 102.
30 Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005 ; 111 : 697-716.   DOI   ScienceOn
31 Dumville JC, Hahn S, Miles JN, Torgerson DJ. The use of unequal randomisation ratios in clinical trials: a review. Contemp Clin Trials. 2006 ; 27(1) : 1-12.   DOI   ScienceOn
32 Division of Health Policy, Ministry of Health & Wellfare. 2011 National Health Statistics. Bokjiro website. 2012[cited 2013 December 6]. Available from: URL: http://www.bokjiro.go.kr/data/statusView.do?board_sid=297&data_sid=5951029